vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and MACROGENICS INC (MGNX). Click either name above to swap in a different company.

ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $41.2M, roughly 1.2× MACROGENICS INC). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs 2.6%). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs 43.6%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.

ACTG vs MGNX — Head-to-Head

Bigger by revenue
ACTG
ACTG
1.2× larger
ACTG
$50.1M
$41.2M
MGNX
Growing faster (revenue YoY)
MGNX
MGNX
+110.4% gap
MGNX
113.0%
2.6%
ACTG
Faster 2-yr revenue CAGR
MGNX
MGNX
Annualised
MGNX
112.8%
43.6%
ACTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
MGNX
MGNX
Revenue
$50.1M
$41.2M
Net Profit
$3.4M
Gross Margin
12.8%
Operating Margin
-26.1%
-29.3%
Net Margin
6.8%
Revenue YoY
2.6%
113.0%
Net Profit YoY
125.5%
EPS (diluted)
$0.03
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
MGNX
MGNX
Q4 25
$50.1M
$41.2M
Q3 25
$59.4M
$72.8M
Q2 25
$51.2M
$22.2M
Q1 25
$124.4M
$13.2M
Q4 24
$48.8M
$19.4M
Q3 24
$23.3M
$110.7M
Q2 24
$25.8M
$10.8M
Q1 24
$24.3M
$9.1M
Net Profit
ACTG
ACTG
MGNX
MGNX
Q4 25
$3.4M
Q3 25
$-2.7M
$16.8M
Q2 25
$-3.3M
$-36.3M
Q1 25
$24.3M
$-41.0M
Q4 24
$-13.4M
Q3 24
$-14.0M
$56.3M
Q2 24
$-8.4M
$-55.7M
Q1 24
$-186.0K
$-52.2M
Gross Margin
ACTG
ACTG
MGNX
MGNX
Q4 25
12.8%
Q3 25
21.2%
Q2 25
12.8%
Q1 25
47.4%
Q4 24
17.6%
98.8%
Q3 24
10.1%
99.8%
Q2 24
26.2%
98.4%
Q1 24
49.2%
97.0%
Operating Margin
ACTG
ACTG
MGNX
MGNX
Q4 25
-26.1%
-29.3%
Q3 25
-10.8%
25.6%
Q2 25
-24.2%
-165.3%
Q1 25
30.8%
-323.1%
Q4 24
-32.4%
-273.0%
Q3 24
-44.1%
48.9%
Q2 24
-18.4%
-538.9%
Q1 24
-8.6%
-590.4%
Net Margin
ACTG
ACTG
MGNX
MGNX
Q4 25
6.8%
Q3 25
-4.6%
23.1%
Q2 25
-6.4%
-163.0%
Q1 25
19.5%
-311.1%
Q4 24
-27.5%
Q3 24
-60.0%
50.9%
Q2 24
-32.7%
-515.6%
Q1 24
-0.8%
-573.3%
EPS (diluted)
ACTG
ACTG
MGNX
MGNX
Q4 25
$0.03
$-0.23
Q3 25
$-0.03
$0.27
Q2 25
$-0.03
$-0.57
Q1 25
$0.25
$-0.65
Q4 24
$-0.14
$-0.24
Q3 24
$-0.14
$0.90
Q2 24
$-0.08
$-0.89
Q1 24
$0.00
$-0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
MGNX
MGNX
Cash + ST InvestmentsLiquidity on hand
$306.7M
$57.2M
Total DebtLower is stronger
$91.9M
Stockholders' EquityBook value
$543.5M
$55.6M
Total Assets
$771.0M
$256.8M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
MGNX
MGNX
Q4 25
$306.7M
$57.2M
Q3 25
$301.8M
$80.1M
Q2 25
$316.7M
$130.7M
Q1 25
$272.0M
$145.6M
Q4 24
$273.9M
$182.8M
Q3 24
$410.9M
$179.6M
Q2 24
$441.9M
$83.9M
Q1 24
$498.4M
$80.4M
Total Debt
ACTG
ACTG
MGNX
MGNX
Q4 25
$91.9M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACTG
ACTG
MGNX
MGNX
Q4 25
$543.5M
$55.6M
Q3 25
$537.6M
$67.0M
Q2 25
$538.6M
$46.6M
Q1 25
$540.2M
$79.1M
Q4 24
$514.8M
$116.1M
Q3 24
$540.2M
$120.1M
Q2 24
$560.7M
$57.8M
Q1 24
$568.3M
$106.2M
Total Assets
ACTG
ACTG
MGNX
MGNX
Q4 25
$771.0M
$256.8M
Q3 25
$768.9M
$270.8M
Q2 25
$775.5M
$245.4M
Q1 25
$801.6M
$224.6M
Q4 24
$756.4M
$261.7M
Q3 24
$707.6M
$264.5M
Q2 24
$753.6M
$201.1M
Q1 24
$631.7M
$248.3M
Debt / Equity
ACTG
ACTG
MGNX
MGNX
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
MGNX
MGNX
Operating Cash FlowLast quarter
$75.2M
$43.0M
Free Cash FlowOCF − Capex
$42.8M
FCF MarginFCF / Revenue
103.8%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
22.01×
TTM Free Cash FlowTrailing 4 quarters
$-83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
MGNX
MGNX
Q4 25
$75.2M
$43.0M
Q3 25
$9.5M
$-30.2M
Q2 25
$50.1M
$-47.0M
Q1 25
$2.4M
$-46.9M
Q4 24
$50.1M
$-38.4M
Q3 24
$-593.0K
$60.2M
Q2 24
$16.1M
$-44.5M
Q1 24
$54.8M
$-45.6M
Free Cash Flow
ACTG
ACTG
MGNX
MGNX
Q4 25
$42.8M
Q3 25
$-30.6M
Q2 25
$-47.7M
Q1 25
$335.0K
$-47.4M
Q4 24
$-98.5M
$-39.0M
Q3 24
$-2.8M
$59.6M
Q2 24
$-126.7M
$-45.5M
Q1 24
$54.6M
$-47.1M
FCF Margin
ACTG
ACTG
MGNX
MGNX
Q4 25
103.8%
Q3 25
-42.0%
Q2 25
-214.5%
Q1 25
0.3%
-359.5%
Q4 24
-201.8%
-201.7%
Q3 24
-12.1%
53.8%
Q2 24
-490.5%
-421.6%
Q1 24
224.4%
-517.4%
Capex Intensity
ACTG
ACTG
MGNX
MGNX
Q4 25
0.6%
Q3 25
0.6%
Q2 25
3.2%
Q1 25
1.7%
4.0%
Q4 24
304.4%
3.2%
Q3 24
9.6%
0.5%
Q2 24
553.0%
9.6%
Q1 24
1.1%
16.0%
Cash Conversion
ACTG
ACTG
MGNX
MGNX
Q4 25
22.01×
Q3 25
-1.79×
Q2 25
Q1 25
0.10×
Q4 24
Q3 24
1.07×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

MGNX
MGNX

Revenue From Collaborative Agreements$20.3M49%
Contract Manufacturing$11.3M27%
Other$9.7M23%

Related Comparisons